<DOC>
	<DOCNO>NCT00480272</DOCNO>
	<brief_summary>Hypothesis : Early intensive treatment anti-TNF agent plus methotrexate plus high dose prednisone may increase remission rate may induce stable remission Rheumatoid Arthritis Objective : evaluate induction remission use adalimumab , prednisone methotrexate maintenance remission discontinuation adalimumab prednisone</brief_summary>
	<brief_title>Prospective Study Intensive Early Rheumatoid Arthritis Treatment</brief_title>
	<detailed_description>Treatment group A 0 - 6 month : Adalimumab 40 mg eow + methotrexate rapidly titrate 20 mg weekly + prednisone 50 mg/d taper 6.25 mg 6 - 12 month : Adalimumab 40 mg eow plus methotrexate 20 mg weekly group B 0 - 6 month : Adalimumab 40 mg eow + methotrexate rapidly titrate 20 mg weekly + placebo 6 - 12 month : Adalimumab 40 mg eow + methotrexate rapidly titrate 20 mg weekly Follow period - Open Label phase : Patients achieve clinical remission treat MTX observe another 12 month period . Patients achieve clinical remission patient experience relapse disease treat accord standard care ( SOC ) modality .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Active rheumatoid arthritis diagnose least 6 week , 1 year , accord revised 1987 ACR criterion Naïve treatment MTX Swollen joint count ( SJC ) &gt; 8 tender joint count ( TJC ) &gt; 8 At screen CRP &gt; 1.5 mg/dL ( 15 mg/L ) ESR ≥ 28 mm/h ≥ 1 joint erosion RF positivity antiCCP positivity Age 1870 year . Rheumatic autoimmune disease RA Functional class IV Any surgical procedure within 12 week prior baseline plan study . Pregnancy breast feed . Evidence significant concomitant disease Primary secondary immunodeficiency active infection kind History previously untreated infection mycobacterium tuberculosis current treatment . History cancer Any history presence congestive heart failure ( CHF ) ( New York Heart Association classification CHF : Class III IV ) . Any history myocardial infarction within 5 year . History severe allergic anaphylactic reaction biologic agent know hypersensitivity component adalimumab methotrexate . Positive serology hepatitis B C indicate active infection . Hemoglobin &lt; 8.0 g/dL . Absolute neutrophil count ( ANC ) &lt; 1.5 x 103/L . Liver function abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>clinical remission</keyword>
</DOC>